Celldex Therapeutics, Inc. (CLDX)
USD 24.82
(-4.69%)
USD 24.82
(-4.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.88 Million | 2.35 Million | 4.65 Million | 7.41 Million | 3.57 Million | 9.53 Million |
| Cost of Revenue | 118.01 Million | 1.4 Million | 3.06 Million | 42.53 Million | 42.67 Million | 66.44 Million |
| Gross Profit | -111.12 Million | 957 Thousand | 1.58 Million | -35.11 Million | -39.09 Million | -56.91 Million |
| Operating Expenses | 43.41 Million | 109.45 Million | 73.79 Million | 56.99 Million | 58.09 Million | 85.94 Million |
| Selling, General and Administrative Expenses | 30.91 Million | 27.19 Million | 20.48 Million | 14.45 Million | 15.42 Million | 19.26 Million |
| Research and Development Expenses | 118.01 Million | 82.25 Million | 53.31 Million | 42.53 Million | 42.67 Million | 66.44 Million |
| Other Expenses | -105.51 Million | 90.34 Million | 55.37 Million | 54.01 Million | 42.7 Million | 224 Thousand |
| Cost and Expenses | 161.42 Million | 109.45 Million | 73.79 Million | 56.99 Million | 58.09 Million | 85.94 Million |
| Operating Income | -154.54 Million | -115.23 Million | -71.24 Million | -63.35 Million | -55.03 Million | -156.43 Million |
| Interest Expense | - | - | - | - | - | 151.09 Million |
| Income Tax Expense | - | 10.45 Million | -227 Thousand | -1.16 Million | -506 Thousand | -765 Thousand |
| Earnings before Tax | -141.42 Million | -112.32 Million | -70.73 Million | -60.94 Million | -50.87 Million | -151.94 Million |
| Net Income | -141.42 Million | -122.78 Million | -70.51 Million | -59.78 Million | -50.37 Million | -151.18 Million |
| Earnings Per Share Basic | -2.92 | -2.62 | -1.64 | -2.02 | -3.47 | -14.48 |
| Earnings Per Share Diluted | -2.92 | -2.62 | -1.64 | -2.02 | -3.47 | -14.48 |
| Weighted Average Shares Outstanding | 48.44 Million | 46.88 Million | 42.87 Million | 29.64 Million | 14.5 Million | 10.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.44 Million | 46.88 Million | 42.87 Million | 29.64 Million | 14.5 Million | 10.44 Million |
| Gross Margin | -16.15 | 0.41 | 0.34 | -4.73 | -10.94 | -5.97 |
| EBIT Margin | -20.20 | -43.22 | -14.53 | -5.15 | -16.28 | -0.07 |
| Profit Margin | -20.55 | -52.09 | -15.16 | -8.06 | -14.10 | -15.85 |
| EBITDA | -139.03 Million | -104.2 Million | -66.08 Million | -45.64 Million | -49.66 Million | -72.6 Million |
| Earnings Before Tax Margin | -22.45 | -48.89 | -15.32 | -8.54 | -15.40 | -16.40 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.49 Million | 156 Thousand | 4.13 Million | 6.88 Million | 1.51 Million | 268 Thousand |
| Cost of Revenue | 797 Thousand | 775 Thousand | 759 Thousand | 3 Million | 767 Thousand | 756 Thousand |
| Gross Profit | 1.7 Million | -619 Thousand | 3.37 Million | 3.87 Million | 750 Thousand | -488 Thousand |
| Operating Expenses | 48.01 Million | 39.98 Million | 38.49 Million | 145.91 Million | 42.75 Million | 33.47 Million |
| Selling, General and Administrative Expenses | 9.12 Million | 9.1 Million | 8.83 Million | - | 8.22 Million | 7.22 Million |
| Research and Development Expenses | 38.89 Million | 30.88 Million | 29.66 Million | - | 34.53 Million | 26.25 Million |
| Other Expenses | -3.88 Million | 31.65 Million | 69.46 Million | 130.23 Million | 34.53 Million | 26.23 Million |
| Cost and Expenses | 48.81 Million | 40.76 Million | 39.25 Million | 148.92 Million | 42.75 Million | 33.47 Million |
| Operating Income | -46.31 Million | -40.6 Million | -35.12 Million | -142.04 Million | -41.23 Million | -33.2 Million |
| Interest Expense | - | - | 3.11 Million | - | - | - |
| Income Tax Expense | - | 731.72 Thousand | 13.38 Million | 2.84 Million | -2.97 Million | -3.45 Million |
| Earnings before Tax | -35.84 Million | -32.8 Million | -43.3 Million | -141.42 Million | -38.26 Million | -30.5 Million |
| Net Income | -35.84 Million | -32.8 Million | -43.3 Million | -141.42 Million | -38.26 Million | -30.5 Million |
| Earnings Per Share Basic | -0.54 | -0.56 | -0.83 | - | -0.81 | -0.65 |
| Earnings Per Share Diluted | -0.54 | -0.56 | -0.83 | - | -0.81 | -0.65 |
| Weighted Average Shares Outstanding | 66.01 Million | 58.87 Million | 52.02 Million | 48.44 Million | 47.26 Million | 47.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 66.01 Million | 58.87 Million | 52.02 Million | 48.44 Million | 47.26 Million | 47.25 Million |
| Gross Margin | 0.68 | -3.97 | 0.82 | 0.56 | 0.49 | -1.82 |
| EBIT Margin | -18.22 | -255.34 | -8.32 | - | -28.64 | -133.99 |
| Profit Margin | -14.35 | -210.31 | -10.48 | -20.55 | -25.22 | -113.81 |
| EBITDA | -45.52 Million | -39.83 Million | -34.36 Million | - | -43.45 Million | -35.9 Million |
| Earnings Before Tax Margin | -18.54 | -260.31 | -8.50 | -20.64 | -27.18 | -123.90 |
CTXXF
HATM
IGN
LGRVF
AAV
DMR